溴隐亭用于诱导无排卵性避孕药后正常催乳素血症患者排卵。
Bromocriptine for induction of ovulation in normoprolactinaemic post-pill anovulation.
作者信息
van der Steeg H J, Bennink H J
出版信息
Lancet. 1977 Mar 5;1(8010):502-4. doi: 10.1016/s0140-6736(77)91369-1.
PMID:65607
Abstract
19 women with anovulation after discontinuing oral contraceptive agents and with normal plasma-prolactin concentrations were treated with bromocriptine. Ovulation and menstruation were restored in 9 of the 13 amenorrhoeic and 5 of the 6 oligomenorrhoeic patients. The success-rate (74%) indicates that bromocriptine is an effective treatment for post-pill anovulation in normoprolactinaemic women.
摘要
19名停用口服避孕药后无排卵且血浆催乳素浓度正常的女性接受了溴隐亭治疗。13名闭经患者中有9名、6名月经过少患者中有5名恢复了排卵和月经。成功率（74%）表明，溴隐亭对催乳素正常的女性 pill 后无排卵是一种有效的治疗方法。
Zotero 插件